NCT07798986

Brief Summary

Generalized anxiety disorder (GAD) is a common mental disorder characterized by persistent excessive worry, which seriously affects patients' quality of life. Electroacupuncture (EA) has been widely used in the clinical treatment of anxiety disorders, but the optimal stimulation parameters remain unclear. This study will adopt a randomized controlled trial (RCT) design to systematically compare the clinical efficacy of three different EA stimulation parameters (2 Hz continuous wave, 100 Hz continuous wave, and 2 Hz/100 Hz dense-disperse wave) in patients with GAD. Multidimensional outcome assessment tools will be used to comprehensively evaluate the therapeutic effects of different stimulation modes. The results of this study are expected to provide evidence-based reference for the selection of electroacupuncture parameters in the treatment of GAD, so as to optimize the clinical treatment regimen and improve the therapeutic effect.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
27mo left

Started Sep 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress4%
Sep 2026Dec 2028

First Submitted

Initial submission to the registry

June 24, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2026

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 2, 2026

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

September 2, 2026

Status Verified

June 1, 2026

Enrollment Period

2.2 years

First QC Date

June 24, 2026

Last Update Submit

August 31, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • the score of Hamilton anxiety rating scale, HAMA

    This scale consists of 14 items. Trained physicians or assessors conduct a semi-structured interview to rate the subject's recent anxiety symptoms. The items cover two major dimensions: psychic anxiety (e.g., tension, fear) and somatic anxiety (e.g., muscle tension, cardiovascular symptoms).A higher score indicates more severe symptoms, with 7 set as the cut-off value.

    week 0, week 4, week 8 and week 16 after enrollment

Secondary Outcomes (3)

  • the score of Zung self-rating anxiety scale, SAS

    week 0, week 4, week 8 and week 16 after enrollment

  • the score of Pittsburgh sleep quality index, PSQI

    week 0, week 4, week 8 and week 16 after enrollment

  • the score of Short form-12 health survey, SF-12

    week 0, week 4, week 8 and week 16 after enrollment

Other Outcomes (3)

  • Number of participants with treatment-related adverse events as assessed by CTCAE v4.0

    From enrollment to the end of treatment at 4 weeks

  • acupuncture compliance rate

    4 weeks after treatment

  • the level of Heart Rate Variability

    week 0 and week 6 after enrollment

Study Arms (4)

sham electroacupuncture group (SEA group)

SHAM COMPARATOR

In the SEA group, shallow punctures were made at the points 1 cm outward/radially from bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6), and Sishencong (EX-HN1) respectively, and then the power was cut off after connecting the electro - acupuncture device.Each treatment lasts 30 minutes, with 3 treatments per week for 4 consecutive weeks, totaling 12 treatments.

Device: sham electro-acupunctureOther: manual acupuncture

2Hz continuous wave electroacupuncture group (2Hz EA group)

EXPERIMENTAL

Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 2Hz. 30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.

Device: 2Hz electro-acupunctureOther: manual acupuncture

100Hz continuous wave electroacupuncture group (100Hz EA group)

EXPERIMENTAL

Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz. 30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.

Device: 100Hz electro-acupunctureOther: manual acupuncture

2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)

EXPERIMENTAL

Needles are routinely inserted at bilateral Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1). Electroacupuncture is applied to bilateral Shenmen-Neiguan pairs, with intensity adjusted to subject tolerance, and frequencies of 100Hz. 30 minutes per session, 3 sessions weekly for 4 consecutive weeks, 12 sessions total.

Device: 2Hz/100Hz electro-acupunctureOther: manual acupuncture

Interventions

After connecting the electro - acupuncture device, the power was cut off for 30 minutes each time.Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.

sham electroacupuncture group (SEA group)

Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints. The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz for 30 minutes each time. Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.

2Hz continuous wave electroacupuncture group (2Hz EA group)

Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints. The intensity was set to the level that the subjects could tolerate, and the frequencies were 2Hz/100Hz for 30 minutes each time. Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.

2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)

Needles with a specification of 0.25Ă—25mm were selected. Manual acupuncture is performed at the acupoints of Neiguan (PC6), Shenmen (HT7), Taichong (LR3), Sanyinjiao (SP6) and Sishencong (EX-HN1).

100Hz continuous wave electroacupuncture group (100Hz EA group)2Hz continuous wave electroacupuncture group (2Hz EA group)2Hz/100Hz dense-disperse wave electroacupuncture group (2Hz/100Hz EA group)sham electroacupuncture group (SEA group)

Electro-acupuncture device was connected to the bilateral Shenmen (HT7) and Neiguan (PC6) acupoints. The intensity was set to the level that the subjects could tolerate, and the frequencies were 100Hz for 30 minutes each time. Treatment was carried out 3 times a week for 4 consecutive weeks, a total of 12 times.

100Hz continuous wave electroacupuncture group (100Hz EA group)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Only those who meet the following four criteria simultaneously can be included in this study:
  • Meet the diagnostic criteria for GAD;
  • Between 18 and 60 years old;
  • Conscious and able to communicate normally;
  • Have good compliance, be willing to cooperate with the study, and sign the informed consent form.

You may not qualify if:

  • Exclude patients meeting any of the following criteria:
  • Organic mental disorder, schizophrenia, bipolar disorder, mania/other psychoses, alcohol/drug addiction, current drug use disorder/lifetime drug abuse, post-stroke/postpartum anxiety;
  • History of suicidal behavior or severe suicidal tendency;
  • Pregnancy or breastfeeding;
  • Mental retardation, unable to cooperate;
  • Electroacupuncture contraindications: bleeding tendency, coagulation dysfunction, internal metal implants;
  • Participation in other clinical trials within 1 month.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University, China

Hangzhou, Zhejiang, China

Location

MeSH Terms

Conditions

Generalized Anxiety Disorder

Condition Hierarchy (Ancestors)

Anxiety DisordersMental Disorders

Central Study Contacts

Xiaoting Wu, Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2026

First Posted

September 2, 2026

Study Start

September 1, 2026

Primary Completion (Estimated)

October 30, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

September 2, 2026

Record last verified: 2026-06

Locations